Will FDA approve Apitegromab for SMA by end of 2024? | Binary | | | 3 months ago | |
Scholar Rock stock price increase by 100% by end of 2024? | Binary | | | 3 months ago | |
FDA approval of Apitegromab for SMA by October 2025? | Binary | | | 3 months ago | |
Major pharma partnership or acquisition with Scholar Rock by 2025? | Categorical | | | 3 months ago | |
Will Scholar Rock's apitegromab receive FDA approval for SMA treatment by end of 2025? | Binary | | | 3 months ago | |
Will Scholar Rock's stock price remain 200% above pre-trial levels by April 2025? | Binary | | | 3 months ago | |
Will Scholar Rock announce a partnership or acquisition deal related to apitegromab by mid-2025? | Binary | | | 3 months ago | |
Will Scholar Rock announce a partnership with a major pharmaceutical company by March 2025? | Binary | | | 3 months ago | |
Will Scholar Rock's stock maintain a 200% increase by end of January 2025? | Binary | | | 3 months ago | |
What will Scholar Rock's revenue from Apitegromab be in 2025? | Categorical | | | 3 months ago | |
Apitegromab included in WHO Essential Medicines List by 2025? | Binary | | | 3 months ago | |
Region approving Apitegromab for SMA first after US by 2025? | Categorical | | | 3 months ago | |
Primary treatment type approval for Apitegromab by 2025? | Categorical | | | 3 months ago | |
What will be the next significant corporate action by Scholar Rock by end of 2025? | Categorical | | | 3 months ago | |
What will be the next major regulatory milestone for Scholar Rock's apitegromab by end of 2025? | Categorical | | | 3 months ago | |
What will be Scholar Rock's market position in SMA treatments by end of 2025? | Categorical | | | 3 months ago | |
What will be the next regulatory milestone for Apitegromab by mid-2025? | Categorical | | | 3 months ago | |
Which SMA treatment will have the largest market share in 2025? | Categorical | | | 3 months ago | |
